Cited by 204Autophagy in Disease and TherapyCalcium signaling and nucleotide metabolismCellular transport and secretion

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index; 19 of the 33 sources its claims cite were checked for support.

TFEB regulates lysosomal positioning by modulating TMEM55B expression and JIP4 recruitment to lysosomes

Open access

Abstract

Lysosomal distribution is linked to the role of lysosomes in many cellular functions, including autophagosome degradation, cholesterol homeostasis, antigen presentation, and cell invasion. Alterations in lysosomal positioning contribute to different human pathologies, such as cancer, neurodegeneration, and lysosomal storage diseases. Here we report the identification of a novel mechanism of lysosomal trafficking regulation. We found that the lysosomal transmembrane protein TMEM55B recruits JIP4 to the lysosomal surface, inducing dynein-dependent transport of lysosomes toward the microtubules minus-end. TMEM55B overexpression causes lysosomes to collapse into the cell center, whereas depletion of either TMEM55B or JIP4 results in dispersion toward the cell periphery. TMEM55B levels are transcriptionally upregulated following TFEB and TFE3 activation by starvation or cholesterol-induced lysosomal stress. TMEM55B or JIP4 depletion abolishes starvation-induced retrograde lysosomal transport and prevents autophagosome–lysosome fusion. Overall our data suggest that the TFEB/TMEM55B/JIP4 pathway coordinates lysosome movement in response to a variety of stress conditions.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

The paper identifies TMEM55B as a lysosomal transmembrane protein that recruits JIP4 to lysosomes, promoting dynein-dependent retrograde transport and perinuclear lysosome clustering. TFEB/TFE3 upregulate TMEM55B under starvation or cholesterol stress, and TMEM55B/JIP4 depletion blocks starvation-induced lysosomal clustering and autophagosome–lysosome fusion.

Key findings

  • TMEM55B overexpression clusters lysosomes in the cell center, while TMEM55B depletion causes over 80% reduction in TMEM55B mRNA/protein and shifts lysosomes toward the cell periphery; JIP4 depletion causes more than 60% of LAMP-1 signal to fall >15 μm from the nuclear rim.
  • TMEM55B’s cytosolic domain recruits JIP4 to lysosomal membranes; in JIP4-depleted cells, GFP-TMEM55B fails to cluster lysosomes, with distal LAMP-1 signal >15 μm changing from 20% in control cells to more than 50%.
  • Starvation increases TMEM55B mRNA/protein in a TFEB/TFE3-dependent manner; starvation-induced lysosomal clustering is reduced in TFEB-depleted cells and blocked by TMEM55B or JIP4 depletion, and JIP4 depletion reduces LC3II accumulation after EBSS plus bafilomycin.
  • U18666A-induced cholesterol stress and NPC1 patient fibroblasts upregulate TMEM55B; JIP4 depletion reduces perinuclear clustering in NPC fibroblasts, and acute curcumin/NaAsO2 stress induces JIP4/p150Glued recruitment and lysosomal clustering via p38, not JNK or ERK.

Methods

  • Cell culture and perturbations: ARPE-19, HeLa, U2OS, MEFs, and NPC1/control fibroblasts were subjected to siRNA/shRNA knockdown, adenoviral expression, rapamycin-induced dimerization, nocodazole, starvation, U18666A, curcumin/NaAsO2, and MAPK inhibitors.
  • Imaging and quantification: immunofluorescence for LAMP-1, JIP4, p150Glued, and other markers; lysosome distribution measured by linear profile, radial profile, and cumulative intensity distribution; time-lapse confocal microscopy; statistics by two-tailed t-test or one-way ANOVA.
  • Biochemical assays: qRT-PCR, immunoblotting, GFP/RFP pull-downs, mass spectrometry, subcellular fractionation, and phosphatidylinositol phosphatase assays including malachite green and PH-PLCD1 imaging.

Limitations

  • The paper states that it remains to be determined whether TMEM55B functions as a mere JIP4 recruiter or also stimulates the interaction between JIP4 and the dynein–dynactin complex, and how the TMEM55B/JIP4 pathway works in conjunction with other retrograde pathways such as Rab7/RILP/ORP1L and MCOLN1/ALG-2.
  • Evident from the text: mechanistic conclusions rely largely on cultured cell lines with overexpression, RNAi, and pharmacological stress, with no in vivo animal model or direct structural mapping of the TMEM55B–JIP4 interface presented.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-017-01871-z

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 TMEM55B regulates lysosomal positioning. a Schematic of the predicted membrane topology of TMEM55B. b ARPE-19 cells transfected with GFP-TMEM55B for 18 h. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1 (top) or HRS (bottom). Insets represent a 3.2- (top) and 4.5- (bottom) fold magnification of the indicated areas. c ARPE-19 cells infected with adenovirus expressing GFP-TMEM55B for 30 h. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1 (top) or EEA1 (bottom). Arrows denote bulk of lysosomal accumulation. d HeLa cells infected with adenovirus expressing GFP-TMEM55B for 30 h. Cells were fixed permeabilized and immunostained with antibodies against LAMP-1. Arrows denote bulk of lysosomal accumulation. e, f HeLa cells treated with TMEM55B or Control siRNAs for 6 days. e Relative quantitative real-time PCR analysis of TMEM55B mRNA transcript levels (mean ± s.e.m. of the RNA fold change of indicated TMEM55B normalized to actin mRNA from three independent experiments; ∗∗∗ P < 0.0001). f Immunoblot of lysates of cells treated with TMEM55B or Control siRNA. g HeLa cells treated with TMEM55B or Control siRNA were immunostained with antibody against LAMP-1. h Quantification of lysosome distribution, percentage of total fluorescence signal detected at 0–5 μm, 5–15 μm, or >15 μm from nuclear rim. Quantified results are presented as mean ± s.e.m. using two-tailed t-test ∗ P < 0.05, ∗∗ P < 0.005 were considered significant, n ≥ 30 from three or more independent experiments. Scale bars, 20 μm
Fig. 1 TMEM55B regulates lysosomal positioning. a Schematic of the predicted membrane topology of TMEM55B. b ARPE-19 cells transfected with GFP-TMEM55B for 18 h. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1 (top) or HRS (bottom). Insets represent a 3.2- (top) and 4.5- (bottom) fold magnification of the indicated areas. c ARPE-19 cells infected with adenovirus expressing GFP-TMEM55B for 30 h. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1 (top) or EEA1 (bottom). Arrows denote bulk of lysosomal accumulation. d HeLa cells infected with adenovirus expressing GFP-TMEM55B for 30 h. Cells were fixed permeabilized and immunostained with antibodies against LAMP-1. Arrows denote bulk of lysosomal accumulation. e, f HeLa cells treated with TMEM55B or Control siRNAs for 6 days. e Relative quantitative real-time PCR analysis of TMEM55B mRNA transcript levels (mean ± s.e.m. of the RNA fold change of indicated TMEM55B normalized to actin mRNA from three independent experiments; ∗∗∗ P < 0.0001). f Immunoblot of lysates of cells treated with TMEM55B or Control siRNA. g HeLa cells treated with TMEM55B or Control siRNA were immunostained with antibody against LAMP-1. h Quantification of lysosome distribution, percentage of total fluorescence signal detected at 0–5 μm, 5–15 μm, or >15 μm from nuclear rim. Quantified results are presented as mean ± s.e.m. using two-tailed t-test ∗ P < 0.05, ∗∗ P < 0.005 were considered significant, n ≥ 30 from three or more independent experiments. Scale bars, 20 μmCC BY · PubMed Central
Fig. 2 Microtubules and Dynein are required for TMEM55B-induced lysosome clustering. a ARPE-19 cells were transfected with 3×HA-TMEM55B and treated with 10 μM nocodazole for 2 h at 37 °C and then shifted to ice for 30 min in the presence of nocodazole. For nocodazole washouts, cells were washed and incubated in nocodazole-free culture medium for the indicated times. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1 and HA. b ARPE-19 cells co-transfected with 3xHA-TMEM55B and GFP-P50 Dynamitin. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1. Insets represent a three-fold magnification of the indicated area. Arrows indicate TMEM55B-induced lysosomal clustering. Scale bars, 20 μm
Fig. 2 Microtubules and Dynein are required for TMEM55B-induced lysosome clustering. a ARPE-19 cells were transfected with 3×HA-TMEM55B and treated with 10 μM nocodazole for 2 h at 37 °C and then shifted to ice for 30 min in the presence of nocodazole. For nocodazole washouts, cells were washed and incubated in nocodazole-free culture medium for the indicated times. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1 and HA. b ARPE-19 cells co-transfected with 3xHA-TMEM55B and GFP-P50 Dynamitin. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1. Insets represent a three-fold magnification of the indicated area. Arrows indicate TMEM55B-induced lysosomal clustering. Scale bars, 20 μmCC BY · PubMed Central
Fig. 3 Recruitment of TMEM55B CD initiates retrograde transport of tagged membranes towards the cell center. ARPE-19 cells transfected with a LAMP-1-CFP-FRB and RFP-FKBP-TMEM55B CD, b Melanoregulin (Mreg 1-42)-CFP-FRB and RFP-FKBP-TMEM55B CD, or c AKAP1-FRB-GFP and RFP-FKBP-TMEM55B CD. Cells were incubated in 200 nM Rapamycin for the indicated times. Cells were fixed, permeabilized, and immunostained with antibodies against CD63 (a, b) or LAMP-1 (c). Arrows indicate TMEM55B CD-induced lysosomal clustering. Scale bars, 10 μm (a, c) or 20 μm (b)
Fig. 3 Recruitment of TMEM55B CD initiates retrograde transport of tagged membranes towards the cell center. ARPE-19 cells transfected with a LAMP-1-CFP-FRB and RFP-FKBP-TMEM55B CD, b Melanoregulin (Mreg 1-42)-CFP-FRB and RFP-FKBP-TMEM55B CD, or c AKAP1-FRB-GFP and RFP-FKBP-TMEM55B CD. Cells were incubated in 200 nM Rapamycin for the indicated times. Cells were fixed, permeabilized, and immunostained with antibodies against CD63 (a, b) or LAMP-1 (c). Arrows indicate TMEM55B CD-induced lysosomal clustering. Scale bars, 10 μm (a, c) or 20 μm (b)CC BY · PubMed Central
Fig. 4 TMEM55B interacts with Dynein adapter JIP4. a Immunoblot of RFP pull-down from lysates of ARPE-19 cells co-transfected with LAMP-1-CFP-FRB and RFP-FKBP-TMEM55B CD and treated with 200 nM Rapamycin (Rap) (+) or vehicle (−) for 2 h. b Immunoblot of GFP pull-down from lysates of ARPE-19 cells transfected with GFP-TMEM55B FL (full length), GFP-TMEM55B CD (cytosolic domain), GFP-TMEM55A FL, or GFP-TMEM55A CD. c Immunoblot of GFP pull-down from lysates of ARPE-19 cells transfected with GFP-LAMP-1 or GFP. d Immunoblot of GFP pull-down from lysates of ARPE-19 cells transfected with GFP-TMEM55B FL or GFP-TMEM55B CD. e Immunoblot of GFP pull-down from lysates of ARPE-19 cells co-transfected with GFP-LAMP-1 and 3xHA-TMEM55B. f ARPE-19 cells were infected with adenovirus expressing GFP (top) or GFP-TMEM55B (bottom) for 24 h. Cells were fixed, permeabilized, and immunostained with antibodies against JIP4 and LAMP-1. Insets represent a 2.8-fold magnification of the indicated areas. Scale bars, 20 μm
Fig. 4 TMEM55B interacts with Dynein adapter JIP4. a Immunoblot of RFP pull-down from lysates of ARPE-19 cells co-transfected with LAMP-1-CFP-FRB and RFP-FKBP-TMEM55B CD and treated with 200 nM Rapamycin (Rap) (+) or vehicle (−) for 2 h. b Immunoblot of GFP pull-down from lysates of ARPE-19 cells transfected with GFP-TMEM55B FL (full length), GFP-TMEM55B CD (cytosolic domain), GFP-TMEM55A FL, or GFP-TMEM55A CD. c Immunoblot of GFP pull-down from lysates of ARPE-19 cells transfected with GFP-LAMP-1 or GFP. d Immunoblot of GFP pull-down from lysates of ARPE-19 cells transfected with GFP-TMEM55B FL or GFP-TMEM55B CD. e Immunoblot of GFP pull-down from lysates of ARPE-19 cells co-transfected with GFP-LAMP-1 and 3xHA-TMEM55B. f ARPE-19 cells were infected with adenovirus expressing GFP (top) or GFP-TMEM55B (bottom) for 24 h. Cells were fixed, permeabilized, and immunostained with antibodies against JIP4 and LAMP-1. Insets represent a 2.8-fold magnification of the indicated areas. Scale bars, 20 μmCC BY · PubMed Central
Fig. 5 TMEM55B/JIP4 drive retrograde lysosomal trafficking independent of RILP. a HeLa cells treated with JIP4 or Control siRNA were immunostained with antibody against LAMP-1. b Quantification of lysosome distribution shown as the percentage of total fluorescence signal detected at 0–5 μm, 5–15 μm, or >15 μm from nuclear rim. Quantified results are presented as mean ± s.e.m. using two-tailed t-test ∗ P < 0.05, ∗∗ P < 0.005 were considered significant, n ≥ 30. c Immunoblot of HeLa cells depleted of JIP4 or Control RNAi. d HeLa cells treated with JIP4 or Control siRNA were infected with adenovirus expressing GFP-TMEM55B for 24 h. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1. Arrows denote bulk of lysosomal accumulation. e Quantification of lysosome distribution, percentage of total fluorescence signal detected at 0–5 μm or >15 μm from nuclear rim. Quantified results are presented as mean ± s.e.m. using two-tailed t-test ∗ P < 0.05, ∗∗ P < 0.005 were considered significant, n ≥ 10. f HeLa cells depleted of TMEM55B, JIP4, or expressing control RNAis were transfected with GFP-RILP for 24 h. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1. Arrows denote bulk of lysosomal accumulation. Scale bars, 20 μm
Fig. 5 TMEM55B/JIP4 drive retrograde lysosomal trafficking independent of RILP. a HeLa cells treated with JIP4 or Control siRNA were immunostained with antibody against LAMP-1. b Quantification of lysosome distribution shown as the percentage of total fluorescence signal detected at 0–5 μm, 5–15 μm, or >15 μm from nuclear rim. Quantified results are presented as mean ± s.e.m. using two-tailed t-test ∗ P < 0.05, ∗∗ P < 0.005 were considered significant, n ≥ 30. c Immunoblot of HeLa cells depleted of JIP4 or Control RNAi. d HeLa cells treated with JIP4 or Control siRNA were infected with adenovirus expressing GFP-TMEM55B for 24 h. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1. Arrows denote bulk of lysosomal accumulation. e Quantification of lysosome distribution, percentage of total fluorescence signal detected at 0–5 μm or >15 μm from nuclear rim. Quantified results are presented as mean ± s.e.m. using two-tailed t-test ∗ P < 0.05, ∗∗ P < 0.005 were considered significant, n ≥ 10. f HeLa cells depleted of TMEM55B, JIP4, or expressing control RNAis were transfected with GFP-RILP for 24 h. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1. Arrows denote bulk of lysosomal accumulation. Scale bars, 20 μmCC BY · PubMed Central
Fig. 6 TFE3 and TFEB increase TMEM55B expression to cluster lysosomes during starvation. a–c ARPE-19 cells were infected with adenovirus expressing TFE3-S321A-Myc, TFEB-S211A-FLAG, or null virus for 36 h. a Relative quantitative real-time PCR analysis of TMEM55B mRNA transcript levels (mean ± s.e.m. of the RNA fold change of indicated TMEM55B normalized to GAPDH mRNA, n = 4). b Representative immunoblot of lysates from TFE3-S321A-Myc and TFEB-S211A-FLAG expressing cells. c Quantification of TMEM55B protein levels. d Control MEFs untreated or starved in EBSS for 4 h. Cells were fixed, permeabilized, and immunostained with antibodies against TFE3. e–g Relative quantitative real-time PCR analysis of e MCOLN1, f TMEM55B and g TMEM55A mRNA transcript levels from null- or TFE3/TFEB knockout MEFs, untreated or starved in EBSS for 4 h (mean ± s.e.m. of the RNA fold change of indicated TMEM55B normalized to GAPDH) n = 6 from three independent experiments. h HeLa cells stably expressing control or TFEB shRNAs were starved in EBSS for 4 h. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1. i HeLa cells expressing control, TMEM55B, and JIP4 RNAis were starved in EBSS for 4 h. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1. j Quantification of lysosome distribution, percentage of total fluorescence signal detected >15 μm from nuclear rim. Quantified results are presented as mean ± s.e.m. using two-tailed t-test ∗ P < 0.05, ∗∗ P < 0.005 were considered significant, n ≥ 30. k Immunoblot of lysates from HeLa cells treated with siControl or siJIP4 siRNA, then starved in EBSS for 4 h, or starved in EBSS for 4 h with 2 h 100 nM bafilomycin. Note that all the samples were run in the same gel but are presented in two panels due to space limitations. l quantification of LC3II/Actin ratios from siControl or siJIP4-treated HeLa cells starved in EBSS 4 h with 100 nM bafilomycin for 2 h. Quantified results are fold increase of LC3II/Actin from siControl after starvation and bafilomycin treatment and data are presented as mean ± s.e.m. using two-tailed t-test **P < 0.005, n = 3. m HeLa cells treated with siControl or siJIP4 siRNA and starved with EBSS for 4 h and 100 nM bafilomycin for 2 h. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1, LC3, and DAPI. Scale bars, 20 μm
Fig. 6 TFE3 and TFEB increase TMEM55B expression to cluster lysosomes during starvation. a–c ARPE-19 cells were infected with adenovirus expressing TFE3-S321A-Myc, TFEB-S211A-FLAG, or null virus for 36 h. a Relative quantitative real-time PCR analysis of TMEM55B mRNA transcript levels (mean ± s.e.m. of the RNA fold change of indicated TMEM55B normalized to GAPDH mRNA, n = 4). b Representative immunoblot of lysates from TFE3-S321A-Myc and TFEB-S211A-FLAG expressing cells. c Quantification of TMEM55B protein levels. d Control MEFs untreated or starved in EBSS for 4 h. Cells were fixed, permeabilized, and immunostained with antibodies against TFE3. e–g Relative quantitative real-time PCR analysis of e MCOLN1, f TMEM55B and g TMEM55A mRNA transcript levels from null- or TFE3/TFEB knockout MEFs, untreated or starved in EBSS for 4 h (mean ± s.e.m. of the RNA fold change of indicated TMEM55B normalized to GAPDH) n = 6 from three independent experiments. h HeLa cells stably expressing control or TFEB shRNAs were starved in EBSS for 4 h. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1. i HeLa cells expressing control, TMEM55B, and JIP4 RNAis were starved in EBSS for 4 h. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1. j Quantification of lysosome distribution, percentage of total fluorescence signal detected >15 μm from nuclear rim. Quantified results are presented as mean ± s.e.m. using two-tailed t-test ∗ P < 0.05, ∗∗ P < 0.005 were considered significant, n ≥ 30. k Immunoblot of lysates from HeLa cells treated with siControl or siJIP4 siRNA, then starved in EBSS for 4 h, or starved in EBSS for 4 h with 2 h 100 nM bafilomycin. Note that all the samples were run in the same gel but are presented in two panels due to space limitations. l quantification of LC3II/Actin ratios from siControl or siJIP4-treated HeLa cells starved in EBSS 4 h with 100 nM bafilomycin for 2 h. Quantified results are fold increase of LC3II/Actin from siControl after starvation and bafilomycin treatment and data are presented as mean ± s.e.m. using two-tailed t-test **P < 0.005, n = 3. m HeLa cells treated with siControl or siJIP4 siRNA and starved with EBSS for 4 h and 100 nM bafilomycin for 2 h. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1, LC3, and DAPI. Scale bars, 20 μmCC BY · PubMed Central
Fig. 7 TFEB/3 and SREBF2 co-operate to regulate TMEM55B levels in response to changes in cholesterol levels. a, b HeLa cells were treated with drugs to deplete cellular cholesterol for 120 h, treated with 10 μM U18666A for 18 h, or left untreated. a Relative quantitative real-time PCR analysis of TMEM55B mRNA transcript levels (mean ± s.e.m. of the RNA fold change of indicated TMEM55B normalized to GAPDH mRNA, using two-tailed t-test **P < 0.005 were considered significant) n = 3. b Representative immunoblot of lysates from cholesterol depleted cells. c Control MEFs were untreated or incubated in 10 μM U18666A for 18 h. Cells were fixed, permeabilized, and immunostained with antibodies against TFE3. d Relative quantitative real-time PCR analysis of TMEM55B mRNA transcript levels from null- or TFE3/TFEB knockout MEFs, untreated or starved in EBSS for 4 h (mean ± s.e.m. of the RNA fold change of indicated TMEM55B normalized to GAPDH, using two-tailed t-test *P < 0.05 were considered significant) n = 6 from three independent experiments. e HeLa cells depleted of TMEM55B, JIP4, or control RNAi were starved in EBSS for 4 h and then immunostained with antibody against LAMP-1. f Control MEFs treated with control and SREBF2 siRNAs and TFEB/TFE3 KO MEFs treated with SREBF2 siRNAs were incubated with 10 μM U18666A for 18 h and the TMEM55B mRNA transcript levels were quantified by qRT-PCR (mean ± s.e.m. of the RNA fold change normalized to TMEM55B levels in siControl-treated cells, using two-tailed t-test *P < 0.05, **P < 0.005 were considered significant) n = 6 from three independent experiments. g Immunoblot of lysates from primary skin fibroblasts from Niemann-Pick C (NPC1) patient 1, NPC1 patient 2, and genetic matched control patient. h NPC1 patient fibroblasts depleted of JIP4 with RNAi. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1, JIP4, and DAPI. i Model of TMEM55B transcriptional regulation. Nutrient deprivation inactivates mTOR to allow TFEB/3 translocation to the nucleus to activate transcription of TMEM55B and induce lysosome retrograde trafficking. Decreased sterol levels at the ER stimulates SREBF2 to translocate to the nucleus to activate transcription of TMEM55B and induces lysosome retrograde trafficking. TMEM55B recruits scaffold JIP4 that binds dynein–dynactin motor complex. Scale bars, 20 μm
Fig. 7 TFEB/3 and SREBF2 co-operate to regulate TMEM55B levels in response to changes in cholesterol levels. a, b HeLa cells were treated with drugs to deplete cellular cholesterol for 120 h, treated with 10 μM U18666A for 18 h, or left untreated. a Relative quantitative real-time PCR analysis of TMEM55B mRNA transcript levels (mean ± s.e.m. of the RNA fold change of indicated TMEM55B normalized to GAPDH mRNA, using two-tailed t-test **P < 0.005 were considered significant) n = 3. b Representative immunoblot of lysates from cholesterol depleted cells. c Control MEFs were untreated or incubated in 10 μM U18666A for 18 h. Cells were fixed, permeabilized, and immunostained with antibodies against TFE3. d Relative quantitative real-time PCR analysis of TMEM55B mRNA transcript levels from null- or TFE3/TFEB knockout MEFs, untreated or starved in EBSS for 4 h (mean ± s.e.m. of the RNA fold change of indicated TMEM55B normalized to GAPDH, using two-tailed t-test *P < 0.05 were considered significant) n = 6 from three independent experiments. e HeLa cells depleted of TMEM55B, JIP4, or control RNAi were starved in EBSS for 4 h and then immunostained with antibody against LAMP-1. f Control MEFs treated with control and SREBF2 siRNAs and TFEB/TFE3 KO MEFs treated with SREBF2 siRNAs were incubated with 10 μM U18666A for 18 h and the TMEM55B mRNA transcript levels were quantified by qRT-PCR (mean ± s.e.m. of the RNA fold change normalized to TMEM55B levels in siControl-treated cells, using two-tailed t-test *P < 0.05, **P < 0.005 were considered significant) n = 6 from three independent experiments. g Immunoblot of lysates from primary skin fibroblasts from Niemann-Pick C (NPC1) patient 1, NPC1 patient 2, and genetic matched control patient. h NPC1 patient fibroblasts depleted of JIP4 with RNAi. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1, JIP4, and DAPI. i Model of TMEM55B transcriptional regulation. Nutrient deprivation inactivates mTOR to allow TFEB/3 translocation to the nucleus to activate transcription of TMEM55B and induce lysosome retrograde trafficking. Decreased sterol levels at the ER stimulates SREBF2 to translocate to the nucleus to activate transcription of TMEM55B and induces lysosome retrograde trafficking. TMEM55B recruits scaffold JIP4 that binds dynein–dynactin motor complex. Scale bars, 20 μmCC BY · PubMed Central
Fig. 8 JIP4-dependent retrograde lysosomal transport in response to acute oxidative stress. a, b MEFs were incubated with 20 µM curcumin for the indicated times. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1 (a) or JIP4 and p150Glued (b). c Quantification of cells with JIP4 recruitment to lysosomes in DMSO or curcumin treated MEFs. DMSO n = 745, curcumin n = 805 from three independent experiments. Error bars denote s.e.m. P value calculated using two-tailed t-test ****P < 0.0001. d MEFs treated with control or JIP4 siRNAs and incubated with curcumin for 4 h. Cells were fixed, permeabilized, and immunostained with antibody against LAMP-1. e Immunoblot of U2OS expressing GFP-TMEM55B cells untreated or treated with 150 µM NaAsO2. f Immunoblot of lysates from MEFs treated with curcumin for the indicated times. g MEFs were pre-incubated with MAPK inhibitors, followed by combination of inhibitors and curcumin. Cells were fixed, permeabilized, and immunostained with antibody against LAMP-1. h Quantification of cells with JIP4 recruitment to lysosomes in curcumin/MAPK inhibitor-treated MEFs. Control n = 568, curcumin n = 583, curcumin + p38 inhibitor (20 µM) n = 598, curcumin + JNK inhibitor (25 µM) n = 590, curcumin + ERK inhibitor (20 µM) n = 575 from two independent experiments. Error bars denote s.e.m. P value calculated using one-way ANOVA ***P < 0.001. Scale bars, 20 μm
Fig. 8 JIP4-dependent retrograde lysosomal transport in response to acute oxidative stress. a, b MEFs were incubated with 20 µM curcumin for the indicated times. Cells were fixed, permeabilized, and immunostained with antibodies against LAMP-1 (a) or JIP4 and p150Glued (b). c Quantification of cells with JIP4 recruitment to lysosomes in DMSO or curcumin treated MEFs. DMSO n = 745, curcumin n = 805 from three independent experiments. Error bars denote s.e.m. P value calculated using two-tailed t-test ****P < 0.0001. d MEFs treated with control or JIP4 siRNAs and incubated with curcumin for 4 h. Cells were fixed, permeabilized, and immunostained with antibody against LAMP-1. e Immunoblot of U2OS expressing GFP-TMEM55B cells untreated or treated with 150 µM NaAsO2. f Immunoblot of lysates from MEFs treated with curcumin for the indicated times. g MEFs were pre-incubated with MAPK inhibitors, followed by combination of inhibitors and curcumin. Cells were fixed, permeabilized, and immunostained with antibody against LAMP-1. h Quantification of cells with JIP4 recruitment to lysosomes in curcumin/MAPK inhibitor-treated MEFs. Control n = 568, curcumin n = 583, curcumin + p38 inhibitor (20 µM) n = 598, curcumin + JNK inhibitor (25 µM) n = 590, curcumin + ERK inhibitor (20 µM) n = 575 from two independent experiments. Error bars denote s.e.m. P value calculated using one-way ANOVA ***P < 0.001. Scale bars, 20 μmCC BY · PubMed Central

Verification

Claims the paper makes

74 Own result · 36 Own interpretation · 10 Partly supported · 9 Own method · 3 No basis given · 2 No full text of the sources · 2 Not checked yet · 1 Supported so far · 1 Couldn’t confirm · accuracy not yet measured

Verify all 3 references — free account

Show all 84 claims

  • Probably not a substantial claim. 24
  • It may state two separate claims as one. 32
  • The quote only partly states this claim. 1
54 of 54
  • The paper relies on this without support.

    Starvation activates TFEB and TFE3.

    “TMEM55B levels are transcriptionally upregulated following TFEB and TFE3 activation by starvation or cholesterol-induced lysosomal stress.”
  • The paper relies on this without support.

    Cholesterol accumulation in lysosomes activates TFEB and TFE3.

    “TMEM55B levels are transcriptionally upregulated following TFEB and TFE3 activation by starvation or cholesterol-induced lysosomal stress.”
  • The paper relies on this without support.

    In non-polarized cells, microtubule minus-ends localize to the perinuclear region, close to the MTOC, whereas plus-ends are directed toward the cell periphery.

    “In non-polarized cells, microtubule minus-ends generally localize to the perinuclear region, close to the microtubule-organizing center (MTOC), whereas the microtubule plus-ends are directed toward the cell periphery.”
  • The paper relies on this without support.

    JIP4 is a dynein adaptor/scaffold that links cargo to dynein–dynactin.

    “we identified the dynein scaffold JIP4 as a major interacting protein of TMEM55B CD”
  • The paper relies on this without support.

    Lysosome transport to the perinuclear region following starvation is critical to facilitate autophagosome–lysosome interactions and controls the rate of autophagosome degradation.

    “Lysosome transport to the perinuclear region following starvation is critical to facilitate autophagosome–lysosome interactions and controls the rate of autophagosome degradation.”
  • The paper relies on this without support.

    U18666A mimics the lack of functional Niemann-Pick type C protein responsible for NPC disease.

    “It is well established that U18666A mimics the lack of functional Niemann-Pick type C protein responsible for the NPC disease.”
  • The paper relies on this without support.

    In NPC1 and other lysosomal diseases, persistent accumulation of cholesterol in late endosomes/lysosomes leads to aberrant lysosomal clustering in the cell center.

    “In NPC1 and other lysosomal diseases, the persistent accumulation of cholesterol in late endosomes/lysosomes leads to aberrant lysosomal clustering in the cell center.”
  • The paper relies on this without support.

    Lysosomes undergo bidirectional transport along microtubules through the opposite activities of dynein and kinesins.

    “Lysosomes undergo bidirectional transport along microtubules through the opposite activities of dynein and kinesins.”
  • The paper relies on this without support.

    LDL-bound cholesterol enters cells via endocytosis and is delivered to lysosomes to be converted into unesterified cholesterol.

    “LDL-bound cholesterol enters cells via endocytosis and it is delivered to lysosomes to be converted into unesterified cholesterol.”
  • The paper relies on this without support.

    Free cholesterol is transferred from lysosomes to other cellular compartments in a process that requires transport and tethering of late endosomes/lysosomes with ER membranes.

    “Free cholesterol is then transferred from lysosomes to other cellular compartments in a process that requires transport and tethering of late endosomes/lysosomes with the endoplasmic reticulum (ER) membranes.”
10 of 10

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 65 references

Cited by

Sorted by citations

See all 204

Metadata

Authors
Willett, R., Martina, J. A., Zewe, J. P., Wills, R., Hammond, G. R. V., & Puertollano, R.
Affiliations
  • National Institutes of Health (US)
  • University of Pittsburgh (US)
Corresponding author
Puertollano, Rosa
Venue
Nature Communications
Published
2017-11-17
Volume
8
Issue
1
Pages
1580-1580
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2770609313
Cited by
201
References
65
Citations by year
2026: 15 · 2025: 31 · 2024: 27 · 2023: 25 · 2022: 28 · 2021: 29 · 2020: 27 · 2019: 10 · 2018: 8
FWCI
4.73
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute
  • National Institute of General Medical Sciences (R35GM119412)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
Keywords
TFEB, JIP4, autophagosome-lysosome fusion, lysosomal trafficking, starvation, lysosomal storage disease, microtubules
MeSH terms
Phosphoinositide Phosphatases, Animals, Chlorocebus aethiops, Gene Expression Regulation, HeLa Cells, Humans, Lysosomes, Microtubules, COS Cells, Protein Transport, Vesicular Transport Proteins, RNA Interference, RNA, Small Interfering, Cell Line, Tumor, Adaptor Proteins, Signal Transducing, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Lysosomal Membrane Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review